Literature DB >> 15107902

A case of human poisoning by salinomycin, an agricultural antibiotic.

Phillipa Story1, Alan Doube.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15107902

Source DB:  PubMed          Journal:  N Z Med J        ISSN： 0028-8446


× No keyword cloud information.
  29 in total

1.  Genomics-driven discovery of the biosynthetic gene cluster of maduramicin and its overproduction in Actinomadura sp. J1-007.

Authors:  Ran Liu; Fang Fang; Ziheng An; Renqiong Huang; Yong Wang; Xiao Sun; Shuai Fu; Aisi Fu; Zixin Deng; Tiangang Liu
Journal:  J Ind Microbiol Biotechnol       Date:  2019-12-18       Impact factor: 3.346

2.  Evaluation of self-emulsified DIM-14 in dogs for oral bioavailability and in Nu/nu mice bearing stem cell lung tumor models for anticancer activity.

Authors:  Apurva R Patel; Ravi Doddapaneni; Terrick Andey; Heather Wilson; Stephen Safe; Mandip Singh
Journal:  J Control Release       Date:  2015-06-14       Impact factor: 9.776

3.  Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells.

Authors:  Desheng Lu; Michael Y Choi; Jian Yu; Januario E Castro; Thomas J Kipps; Dennis A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

4.  Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice.

Authors:  Wolfgang Boehmerle; Hanna Muenzfeld; Andreas Springer; Petra Huehnchen; Matthias Endres
Journal:  J Mol Med (Berl)       Date:  2014-04-27       Impact factor: 4.599

5.  An iTEP-salinomycin nanoparticle that specifically and effectively inhibits metastases of 4T1 orthotopic breast tumors.

Authors:  Peng Zhao; Guiquan Xia; Shuyun Dong; Zhaong-Xing Jiang; Mingnan Chen
Journal:  Biomaterials       Date:  2016-03-22       Impact factor: 12.479

6.  Salinomycin and other ionophores as a new class of antimalarial drugs with transmission-blocking activity.

Authors:  Sarah D'Alessandro; Yolanda Corbett; Denise P Ilboudo; Paola Misiano; Nisha Dahiya; Solomon M Abay; Annette Habluetzel; Romualdo Grande; Maria R Gismondo; Koen J Dechering; Karin M J Koolen; Robert W Sauerwein; Donatella Taramelli; Nicoletta Basilico; Silvia Parapini
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

7.  Salinomycin efficiency assessment in non-tumor (HB4a) and tumor (MCF-7) human breast cells.

Authors:  Andressa Megumi Niwa; Gláucia Fernanda Rocha D Epiro; Lilian Areal Marques; Simone Cristine Semprebon; Daniele Sartori; Lúcia Regina Ribeiro; Mário Sérgio Mantovani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-03-02       Impact factor: 3.000

8.  Salinomycin, a polyether ionophoric antibiotic, inhibits adipogenesis.

Authors:  Maria Szkudlarek-Mikho; Rudel A Saunders; Sook Fan Yap; Yun Fong Ngeow; Khew-Voon Chin
Journal:  Biochem Biophys Res Commun       Date:  2012-10-31       Impact factor: 3.575

9.  P-glycoprotein limits oral availability, brain penetration, and toxicity of an anionic drug, the antibiotic salinomycin.

Authors:  Jurjen S Lagas; Rolf W Sparidans; Robert A B van Waterschoot; Els Wagenaar; Jos H Beijnen; Alfred H Schinkel
Journal:  Antimicrob Agents Chemother       Date:  2008-01-14       Impact factor: 5.191

Review 10.  Salinomycin: a novel anti-cancer agent with known anti-coccidial activities.

Authors:  Shuang Zhou; Fengfei Wang; Eric T Wong; Ekokobe Fonkem; Tze-Chen Hsieh; Joseph M Wu; Erxi Wu
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.